Bioorganic and Medicinal Chemistry Letters p. 339 - 344 (1996)
Update date:2022-08-03
Topics:
Xue
Rafalski
Roderick
Eyermann
Mousa
Olson
DeGrado
A potent centrally constrained series of benzimidazole and benzoxazole glycoprotein IIb/IIIa inhibitors has been discovered based on the solution conformation of a cyclic RGD-containing peptide, DMP 728. The high potency of this series of compounds in the inhibition of platelet aggregation requires a benzamidine as the basic moiety and an α-carbamate or sulfonamide substituted β-alanine as the acidic moiety.
View MoreShanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Changzhou Yongxu Chemical Co.,Ltd
Contact:86-0519-85286591
Address:Room 1812,Wanda Plaza B,Xinbei District,Changzhou,Jiangsu,China
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
LianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Doi:10.1016/0020-1693(95)90040-D
(1995)Doi:10.1023/A:1015054907007
(2002)Doi:10.1021/jo960008k
(1996)Doi:10.1023/A:1012374828303
(2001)Doi:10.1021/ic951550e
(1996)Doi:10.1016/0022-328X(95)05885-S
(1996)